This announcement is a separate document:
共同药业：北京中伦（武汉）律师事务所关于湖北共同药业股份有限公司2024年第三次临时股东大会的法律意见书
Kyodo Pharmaceutical: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Hubei Kyodo Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.